![](/img/cover-not-exists.png)
PMH13 ESTIMATING THE BENEFIT OF LONG-ACTING INJECTABLES FOR SCHIZOPHRENIA TREATMENT IN RWANDA USING A ONE-YEAR COST-CONSEQUENCE MODEL
Thomas, T., Keenan, A., Ngirababyeyi, A., Mwaniki, K., Iyamuremye, J.D., Smith-Swintosky, V., Abraham, E., Kayiteshonga, Y., Rutakayire, B., Kanyandekwe, S.Volume:
22
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2019.04.1058
Date:
May, 2019
File:
PDF, 318 KB
english, 2019